Biopharma LatAm is part of a global series of events launched by Biopharma Asia that gathers more than 2,000 yearly participants. Over the last 3 years, we’ve hosted successful events focused on Mexico only, and now have expanded to include all of Latin America with spotlights on Mexico, Argentina, Chile, Ecuador, Colombia, Chile, Panama, Peru, and Costa Rica.
The key topics that our 500+ executives will tackle include biocomparables, biomanufacturing, clinical trials, orphan drugs, marketing, generics, supply chain, and vaccines. Previous attendees have included: AbbVie, Amgen, AstraZeneca, Becton Dickinson, Brazilian Federal Council of Medicine, Bristol-Myers Squibb, Carnot, Celgene, COFEPRIS, Eli Lilly, GE Healthcare, Genzyme, GlaxoSmithKline, IMSS, Janssen, Johnson & Johnson, Merck, Novartis, Panasonic, Pfizer, Probiomed, Roche, Sanofi Pasteur, and Shire.